Modulation of radiation biomarkers in a randomized phase II study of I-131-MIBG with or without radiation sensitizers for relapsed or refractory neuroblastoma: A report from the NANT Consortium.

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要